Oncology Consortium

Impactful Education Through Innovative Engagement

roy.berger@theoncologyconsortium.com | (516) 729-0303

Kimberly L. Blackwell, MD

Breast Oncology Consortium

Kimberly L. Blackwell is Professor of Medicine and Assistant Professor of Radiation Oncology at Duke University Medical Center. Since 2010, she has served as the director of the Breast Cancer Program in the Duke Cancer Institute, overseeing all basic and translational research programs involving breast cancer patients. Blackwell serves on the national Scientific Advisory Board of the Susan G. Komen Foundation.

Adam Brufsky, MD, PhD

Breast Oncology Consortium

Adam Brufsky, MD, PhD, is Professor of Medicine at the University of Pittsburgh Medical Center Health System and Director of the Magee Women’s Hospital/University of Pittsburgh Cancer Institute Comprehensive Breast Care Center. He is also Associate Chief of the Division of Hematology/Oncology. and Associate Director for Clinical Investigation for the University of Pittsburgh Cancer Institute.

Francisco J. Esteva, MD, PhD, FACP

Breast Oncology Consortium

Dr. Esteva is Professor of Medicine at New York University School of Medicine. He currently serves as Associate Director of Clinical Investigation, Director of Breast Medical Oncology and co-Director of the Breast Cancer Disease Management Group a the Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center.

William J. Gradishar, MD, FACP, FASCO

Breast Oncology Consortium

Dr. William J. Gradishar is the Betsy Bramsen Professor of Breast Oncology in the Division of Hematology and Medical Oncology, Department of Medicine, at the Feinberg School Medicine at Northwestern University in Chicago, Illinois, and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He serves as Director of the Maggie Daley Center for Women’s Cancer Care. He has been Chair of the Annual Lynn Sage Breast Cancer Symposium since its inception 16 years ago. He served as Program Director of the Hematology Oncology Fellowship Training Program at Northwestern for 20 years. His research focuses on the development of novel therapeutics for the treatment of breast cancer.

Lee Schwartzberg, MD, FSCP

Breast and Supportive Care Oncology Consortium

Senior partner and Medical Director at The West Clinic, a 33 physician oncology, hematology and radiology practice in Memphis, TN. He did fellowship training in medical oncology and hematology at Memorial Sloan Kettering Cancer Center, where he also served as Chief Medical Resident and was a founding member of the institutional ethics committee. Dr. Schwartzberg is a Professor of Medicine and Division Chief of Hematology/Oncology at The University of Tennessee Health Science Center. He is President /CMO for ACORN Research, an oncology specific SMO/CRO.

Andrew D. Seidman, MD

Breast Oncology Consortium

Attending physician for the Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, and a Professor of Medicine, Joan and Sanford I. Weill Medical College of Cornell University. Dr. Seidman is the recipient of a Career Development Award from the American Society of Clinical Oncology (ASCO) for his research on the role of the taxanes in breast cancer treatment.

Sandra M. Swain, MD, FACP

Breast Oncology Consortium

Sandra M. Swain, MD, FACP is the Medical Director of the Washington Cancer Institute, of MedStar Washington Hospital Center, in Washington, DC. She is a Professor of Medicine at Georgetown University and Adjunct Professor of Medicine at Uniformed Services University of the Health Sciences. She was previously the Deputy Branch Chief of the Medicine Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH) and was a tenured Principal Investigator. She was also the Chief of the Breast Cancer Section, and Chief of the Cancer Therapeutics Branch.

Debu Tripathy, MD

Breast Oncology Consortium

Debu Tripathy, MD is Professor of Medicine and Chair, Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center. He received a degree in Chemical Engineering from the Massachusetts Institute of Technology and then completed medical school and an internal medicine residency at Duke University followed by a Hematology/Oncology fellowship at the University of California at San Francisco. He was formerly Professor of Clinical Medicine, Co-Leader of the Women’s Cancer Program and held the Priscilla and Art Ulene Chair in Women’s Cancer at the University of Southern California and USC/Norris Comprehensive Cancer Center.

Download Capability Slide

Oncology Consortium | All Rights Reserved 2012-2017
Back to Top